Nutrition 21 Chromax Claims Should Reflect “Real World” Performance – NAD
This article was originally published in The Tan Sheet
Executive Summary
Nutrition 21 should modify performance claims for its newly launched Chromax chromium picolinate product to "more closely mirror the results and limitations in the applicable studies," according to the National Advertising Division
You may also be interested in...
Nutrition 21 Expands Into Cardiovascular Area With Iceland Health Buy
Nutrition 21 strengthens its focus on finished products and gains entry to the omega-3 market with the purchase of fish oil importer and manufacturer Iceland Health
Chromium Picolinate “Insulin Resistance” Qualified Health Claim Clears FDA
FDA approved Nutrition 21's chromium picolinate qualified health claim for reduced risk of insulin resistance that can lead to type 2 diabetes, the firm stated Aug. 29
Avoiding GMP “Showstoppers” Keeps Manufacturers Off FDA’s “Radar”
Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement